Biotech Values

[gfp927z]

Dew, Just wondering if you have some insights into the merits of the injectible monoclonal antibody approach (anti-angiogenesis) now being used to treat wet macular degeneration? My mom has this condition in one eye (rupturing of the retinal blood vessels) and her ophthalmologist is planning to inject one of the anti-angiogenesis Mabs that is nearing FDA approval but is not yet approved. There apparently are several similar treatments, approved and in development (Avastin for example). I'm trying to get some info on how successful this anti-angiogenesis approach has been, and if there is any other/better alternative. Thanks for any info you could provide.